Previous 10 | Next 10 |
2024-01-04 16:19:31 ET Gainers: Molecular Partners ( MOLN ) +14% . Sutro Biopharma ( STRO ) +9% . Ribbon Communications ( RBBN ) +7% . Resources Connection ( RGP ) +7% . Pyxis Oncology ( PYXS ) +6% . Losers: 89bio ( ETN...
2024-01-04 12:34:16 ET More on Mid-day movers & Stocks. Relmada Therapeutics, Inc. (RLMD) Q3 2023 Earnings Call Transcript Relmada And REL-1017: Intriguing Underlying Efficacy In MDD Ahead Of Eventful 2024 Avenue Therapeutics GAAP EPS of $0.06 beats by $0.32 ...
2024-01-04 12:31:41 ET DENVER, Colo., Jan. 4, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Omega Therapeutics Inc (NASDAQ: OMGA), Avenue Therapeutics Inc (NASDAQ: ATXI), Nikola Corp (NASDAQ: NKL...
2024-01-04 07:30:00 ET Summary Dyne Therapeutics' early trial results for DM1 and DMD treatments show dose-dependent improvements, but data is preliminary. Despite promising DYNE-101 and DYNE-251 outcomes, limited participant numbers and short trial durations constrain robust asse...
2024-01-03 16:29:32 ET More on Dyne Therapeutics Dyne surges on positive Phase 1/2 data for muscle disorder candidates Seeking Alpha’s Quant Rating on Dyne Therapeutics For further details see: Dyne Therapeutics commences public offering of $175M shares of...
WALTHAM, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that it has commenced an underwr...
2024-01-03 12:43:51 ET More on Mid-day movers & stocks. Tenax falls as rally driven by IND clearance cools Tenax stock jumps after FDA greenlights studies for hypertension candidate Financial information for Airship AI Holdings, Inc. Financial information...
2024-01-03 12:20:37 ET DENVER, Colo., Jan. 3, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Sidus Space Inc (NASDAQ: SIDU), ABVC Biopharma Inc (NASDAQ: ABVC), Dyne Therapeutics Inc (NASDAQ: DYN),...
2024-01-03 10:06:54 ET DENVER, Colo., Jan. 3, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; ABVC Biopharma Inc (NASDAQ: ABVC), Dyne Therapeutics Inc (NASDAQ: DYN), Sidus Space Inc (NASDAQ: SIDU), Neximm...
2024-01-03 10:00:01 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and uti...
News, Short Squeeze, Breakout and More Instantly...
2024-07-21 03:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-24 16:00:09 ET Eun Yang from Jefferies issued a price target of $42.00 for DYN on 2024-06-24 12:31:00. The adjusted price target was set to $42.00. At the time of the announcement, DYN was trading at $35.94. The overall price target consensus is at $38.14 with hi...
WALTHAM, Mass., June 24, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced new preclinical data in a Po...